Clinical Pharmacology

Program Development Strategies (Defining and outlining studies needed for          Regulatory Filings)

Protocol Development for Phase 1-4 studies

PK\PD data analysis and interpretation

Report Writing

Investigator Brochures

Preparation of Clinical Pharmacology Sections for Regulatory submissions             (INDs, NDAs, BLAs, Labeling)

Regulatory Interactions (US, Europe, Japan)

Abstracts, Manuscripts and Posters

Due Diligence Reviews

Services